Avego BioScience Capital — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Immunocoreimmunocore.cominNASDAQ: IMCRJul 2022
Immunocore is a biotechnology company developing T cell receptor (TCR) based immunomodulating therapies for patients with cancer, infectious diseases, and autoimmune diseases.
BiotechHealthtechAbingdon, Oxfordshire
Brian Di Donato(Chief Financial Officer)David Berman(Head of Research and Development)Tina St. Leger(Chief Human Resources Officer)Bahija Jallal(Chief Executive Officer)Robert Perez(Director)Peter Ratcliffe(Director)
Co-investorsJDRF T1D Fund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.